Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
483.80
+2.80 (0.58%)
Jul 31, 2026, 4:08 PM HKT

HKG:6990 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,2441,3371,52992.9681.79
Short-Term Investments
292.57283.98325.87--
Trading Asset Securities
935.311,448633.71--
Cash & Short-Term Investments
4,4723,0692,48892.9681.79
Cash Growth
45.71%23.33%2576.80%13.65%-
Accounts Receivable
97.2760.761.3561.822.73
Other Receivables
193.42183.33123.142.6347.83
Receivables
290.69244.09124.45104.4370.56
Inventory
240.94110.5163.0352.6450.72
Prepaid Expenses
-2.0935.65--
Other Current Assets
145.3267.3396.0182.2995.27
Total Current Assets
5,1493,4932,807332.32298.34
Property, Plant & Equipment
758.5758.11692.73647.82474.17
Long-Term Investments
70.08----
Other Intangible Assets
1.12.581.343.180.49
Other Long-Term Assets
10.2314.518.29.8339.97
Total Assets
5,9894,2683,510993.15812.96

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
426.45291.29404.38327.46325.28
Accrued Expenses
184.53156.34133.7786.6144.72
Short-Term Debt
---2,8912,388
Current Portion of Leases
44.441.8454.4182.261.66
Current Income Taxes Payable
105.463.732.72.52
Current Unearned Revenue
258.03312.38510.69163.98109.04
Other Current Liabilities
81.082.543.03613.57573.72
Total Current Liabilities
1,004809.841,1104,1673,445
Long-Term Leases
44.0484.915.5141.291.25
Long-Term Unearned Revenue
72.9464.664.7410.6810.68
Total Liabilities
1,121959.341,1804,2193,457

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
233.19227.27219.2107.37107.37
Retained Earnings
-4,705-4,323-4,056-3,482-2,866
Comprehensive Income & Other
9,3397,4046,167148.63114.83
Shareholders' Equity
4,8673,3092,329-3,226-2,644
Total Liabilities & Equity
5,9894,2683,510993.15812.96

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
88.44126.7559.923,0142,391
Net Cash (Debt)
4,3832,9422,428-2,921-2,309
Net Cash Growth
48.99%21.15%---
Net Cash Per Share
19.0113.2713.22-30.58-24.98
Filing Date Shares Outstanding
233.19227.27219.2215.8392.46
Total Common Shares Outstanding
233.19227.27219.2107.3792.46
Working Capital
4,1442,6831,697-3,835-3,147
Book Value Per Share
20.8714.5610.63-30.05-28.60
Tangible Book Value
4,8663,3062,328-3,229-2,644
Tangible Book Value Per Share
20.8714.5510.62-30.08-28.60
Buildings
303.68294.1294.4--
Machinery
398.76324.51262.26221.56200.16
Construction In Progress
97.2888.11119.99348.59282.36
Leasehold Improvements
16.616.4714.4513.670.38